Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ninan T Mathew

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Headache|February 16, 2007
Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study)Ninan T Mathew, Gary Finlayson, Timothy R Smith, et al.
Headache|November 24, 2011
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodyniaStewart J Tepper, Shashidhar H Kori, Scott W Borland, et al.
Headache|July 24, 2010
A practice guide for continuous opioid therapy for refractory daily headache: patient selection, physician requirements, and treatment monitoringJoel R Saper, Alvin E Lake, Philip A Bain, et al.
Headache|February 18, 2009
Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine interventionRoger K Cady, Frederick G Freitag, Ninan T Mathew, et al.
Headache|January 7, 2012
Randomized, controlled study of telcagepant in patients with migraine and coronary artery diseaseTony W Ho, Andrew P Ho, Bernard R Chaitman, et al.
Headache|December 7, 2007
The impact of topiramate on health-related quality of life indicators in chronic migraineDavid W Dodick, Stephen Silberstein, Joel Saper, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Headache|February 16, 2007
Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study)Ninan T Mathew, Gary Finlayson, Timothy R Smith, et al.
Headache|November 24, 2011
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodyniaStewart J Tepper, Shashidhar H Kori, Scott W Borland, et al.
Headache|July 24, 2010
A practice guide for continuous opioid therapy for refractory daily headache: patient selection, physician requirements, and treatment monitoringJoel R Saper, Alvin E Lake, Philip A Bain, et al.
Headache|February 18, 2009
Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine interventionRoger K Cady, Frederick G Freitag, Ninan T Mathew, et al.
Headache|January 7, 2012
Randomized, controlled study of telcagepant in patients with migraine and coronary artery diseaseTony W Ho, Andrew P Ho, Bernard R Chaitman, et al.
Headache|December 7, 2007
The impact of topiramate on health-related quality of life indicators in chronic migraineDavid W Dodick, Stephen Silberstein, Joel Saper, et al.
Pageof 4